Targeting Notch-Driven Cytokine Secretion: Novel Therapies for Triple Negative Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Notch-Driven Cytokine Secretion: Novel Therapies for Triple Negative Breast Cancer

Published:2023-02-01 Issue:2 Volume:42 Page:73-81
ISSN:1044-5498
Container-title:DNA and Cell Biology
language:en
Short-container-title:DNA and Cell Biology

Author:

Marini Wanda¹²,Wilson Brooke E.³⁴,Reedijk Michael²⁵^ORCID

Affiliation:

1. Division of General Surgery, University of Toronto, Toronto, Ontario, Canada.

2. Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

3. Department of Oncology, Queen's University, Kingston, Ontario, Canada.

4. Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, Ontario, Canada.

5. Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/dna.2022.0578

Reference113 articles.

1. Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

2. Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

3. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

4. Overall survival, costs and healthcare resource use by number of regimens received in elderly patients with newly diagnosed metastatic triple-negative breast cancer

5. Therapeutic modulation of Notch signalling — are we there yet?

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into Notch signaling in tumor immunity: potential targets for cancer immunotherapy;Frontiers in Immunology;2024-02-20

2. Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2023-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3